文献速递肝病

肝移植在所有衰弱水平均提供生存获益:来自肝移植功能评估多中心研究

Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study.
PubMed 文献 · Hepatology · 2024-07-24

该多中心研究分析2012至2021年等待肝移植的肝硬化患者及已移植患者,按肝衰弱指数(LFI)分层计算1年、3年和5年限制性平均生存时间(RMST)。结果显示移植前和移植后RMST均随LFI升高而下降,但移植前下降更明显;所有LFI值下肝移植均带来净生存获益,无移植前与移植后RMST交叉的阈值。

要点

  • 移植前队列731例(28%)衰弱,440例(17%)在移植前死亡。
  • 移植后队列325例(24%)衰弱,103例(8%)在移植后死亡。
  • 所有LFI值下肝移植均带来净生存获益,由移植前死亡率降低驱动。

核心结论

  • 随着LFI升高,移植前死亡率增加,移植后死亡率增加程度较轻。
  • 肝移植在所有LFI值下均提供生存获益,由移植前死亡率降低驱动。
  • 未发现移植后死亡率超过移植前死亡率的LFI阈值。
  • 即使存在晚期衰弱,在被选择接受肝移植的患者中肝移植仍提供净生存获益。

研究设计与样本

  • 分析肝移植功能评估多中心研究(FrAILT)2012至2021年数据。
  • 移植前队列纳入等待肝移植的无肝细胞癌的可行走肝硬化患者2628例。
  • 移植后队列纳入接受肝移植的患者1335例。
  • 主要结局为移植前和移植后死亡率;从校正Cox模型计算1年、3年和5年限制性平均生存时间(RMST)。
  • 生存获益计算为肝移植带来的净生命年增益。

主要发现

  • 移植前队列中位MELD-Na为18(IQR:14-22),731例(28%)衰弱,440例(17%)在移植前死亡。
  • 移植后队列中位MELD-Na为20(IQR:14-24),325例(24%)衰弱,103例(8%)在移植后死亡。
  • 移植前RMST随LFI升高而大幅下降。
  • 移植后RMST也随LFI升高而下降,但仅轻度下降。
  • 未发现移植前与移植后RMST相交的LFI阈值,所有LFI值下患者均有净生存获益。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Offering LT to frail patients may reduce waitlist mortality but may increase post-LT mortality. LT survival benefit is the concept of balancing these risks. We sought to quantify the net survival benefit with LT by liver frailty index (LFI). APPROACH AND RESULTS: We analyzed data in the multicenter Functional Assessment in LT (FrAILT) study from 2012 to 2021. Pre-LT cohort included ambulatory patients with cirrhosis awaiting LT, without HCC; the post-LT cohort included those who underwent LT. Primary outcomes were pre-LT and post-LT mortality. We computed 1-, 3-, and 5-year restricted mean survival times (RMSTs) from adjusted Cox models. The survival benefit was calculated as a net gain in life-years with LT. Pre-LT cohort included 2628 patients: median Model for End-Stage Liver Disease-Sodium was 18 (IQR: 14-22); 731 (28%) were frail; 440 (17%) died before LT. Post-LT cohort included 1335 patients: median Model for End-Stage Liver Disease-Sodium was 20 (IQR: 14-24); 325 (24%) were frail; 103 (8%) died after LT. Pre-LT RMST decreased substantially as LFI increased. Post-LT RMST also decreased as LFI increased but only modestly. There was no LFI threshold at which pre-LT and post-LT RMST intersected-patients had net survival benefits at all LFI values. CONCLUSIONS: Pre-LT and, to a lesser degree, post-LT mortality increased as LFI increased. Transplant offered a survival benefit at all LFI values, driven by a reduction in pre-LT mortality. No threshold of LFI was identified at which the risk of post-LT mortality exceeded pre-LT mortality. LT offers net survival benefits even in the presence of advanced frailty among those selected for LT.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Wang M, Chiou SH, Ganger D, et al. Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study. Hepatology. 2024. PMID: 39047086. doi:10.1097/HEP.0000000000001030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。